Schedule 13G ownership disclosure
TG THERAPEUTICS INC COM
Common Stock · CUSIP: 88322Q108
Event date: 2024-12-31
- Filing-level shares
- 15,596,480
- Percent of class
- 10.01%
- The Vanguard Group
Shares: 15,596,480 · Class: 10.01%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000038
- Form type
- SCHEDULE 13G/A
- Filer
- TG THERAPEUTICS, INC.
- CIK
- CIK 1001316
- Filed
- Jan 08, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership